Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

Caroline Houillier, Luc Taillandier, Sylvain Dureau, +37

Journal of Clinical Oncology

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

François‐Clément Bidard, William Jacot, Nicolas Kiavué, +22

JAMA Oncology

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Paul Cottu, Véronique D’Hondt, Sylvain Dureau, +19

Annals of Oncology

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer

Emmanuelle Jeannot, Aurélien Latouche, Claire Bonneau, +24

Clinical Cancer Research

PathologyGynecologyCytopathologyHpv CtdnaCancer-associated Virus +16

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study

Caroline Houillier, Sylvain Dureau, Luc Taillandier, +29

Journal of Clinical Oncology

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site

Maud Kamal, Sonia Lameiras, Marc Deloger, +110

British Journal of Cancer

Letrozole and palbociclib versus 3rd generation chemotherapy as neoadjuvant treatment of minal breast cancer. Results of the UNICANCER-eoPAL study

P. Cottu, Véronique D’Hondt, Sylvain Dureau, +17

Annals of Oncology

Minal Breast CancerBreast OncologyUnicancer-eopal StudyGeneration ChemotherapyMedicine +6

Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome

Suzy Scholl, Marina Popović, Anne de la Rochefordière, +51

EBioMedicine

Overall Survival With Circulating Tumor Cell Count–Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial

François‐Clément Bidard, Nicolas Kiavué, William Jacot, +17

Journal of Clinical Oncology

Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial

Marc Hilmi, Maud Kamal, Sophie Vacher, +16

European Journal of Cancer

DysbiosisGut MicrobiologyImmunologyPathologyMetastatic Site +8